Frazier Life Sciences Acquisition Corp. II — Form 8-K
Filed October 22, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Frazier Life Sciences Acquisition Corp. II, a newly formed Cayman Islands blank-check company, closed its IPO on October 15, 2026, issuing 7.5M Class A shares at $10.00/share for gross proceeds of $75M. Simultaneously, the Sponsor purchased 300K Private Placement Shares for $3M. The company holds $75M in a trust account restricted to a qualifying business combination within 24 months; has no target identified and no active negotiations. Public shareholders may redeem shares at IPO price plus pro-rata interest if a business combination is not completed by October 15, 2028, or upon completion of any such combination.
Why this rating
Routine SPAC IPO formation with standard terms and disclosures. No operational business, no identified target, no material business events. Structural event only.
See more from October 22, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.